¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"absorbed dose conversion factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
fermentation factor
¹ßÈ¿ÀÎÀÚ
fertility factor
¼öÅÂÀÎÀÚ
fibrin stabilizing factor
¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ
fibroblast growth factor
¼¶À¯¸ð¼¼Æ÷¼ºÀåÀÎÀÚ
factor
1. ÀÎÀÚ 2. ¿äÀÎ 3. °è¼ö
factor III
Á¦3ÀÎÀÚ
factor IV
Á¦4ÀÎÀÚ
factor IX
Á¦9ÀÎÀÚ
factor IX complex
Á¦9ÀÎÀÚº¹ÇÕü
factor V
Á¦5ÀÎÀÚ
factor VI
Á¦6ÀÎÀÚ
factor VII
Á¦7ÀÎÀÚ
factor VIII
Á¦8ÀÎÀÚ
factor X
Á¦10ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
corticotropin releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢À¯¹ßÀÎÀÚ
dilution factor
¹±ÈûÀÎÀÚ, Èñ¼®ÀÎÀÚ
drug resistance factor
¾àÁ¦ÀúÇ×ÀÎÀÚ
elongation factor
´ÃÀÓÀÎÀÚ, ¿¬ÀåÀÎÀÚ
endothelium-derived contracting factor
³»ÇǼ¼Æ÷¼öÃàÀÎÀÚ
endothelium-derived relaxing factor
³»ÇǼ¼Æ÷ÀÌ¿ÏÀÎÀÚ
endurance factor
Áö¼ÓÀÎÀÚ
eosinophil chemotactic factor
È£»ê±¸ÈÇÐÁÖ¼ºÀÎÀÚ, È£»ê±¸ÈÇнò¸²ÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
exogenous factor
¿ÜÀοä¼Ò
extrinsic factor
¿ÜÀÎÀÎÀÚ, ¿ÜÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
antigen, colonization factor
Áý¶ôÇü¼ºÀÎÀÚÇ׿ø, ¼¼Æ÷±ºÇü¼ºÀÎÀÚÇ׿ø
antihemophilic A factor =AHA
Ç×Ç÷¿ìº´ AÀÎÀÚ(?ËöËö).
antihemophilic factor =AHF
Ç×Ç÷¿ìº´ÀÎÀÚ(¡ì×í)
antihemophilic factor =AHF
Ç×Ç÷¿ìº´ÀÎÀÚ(?ËöËö).
antihemophllic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antiinsulin factor
Ç×Àν¶¸°ÀÎÀÚ.
antineuritic factor
Ç׽Ű濰ÀÎÀÚ(ù÷ãêÌèæúì×í).
antinuclear factor =ANF
Ç×ÇÙÀÎÀÚ.
antipellagra factor
Çׯç¶ó±×¶óÀÎÀÚ.
antiphagocytic factor
Ç׎½ÄÀÎÀÚ, Ç׽ıÕÀÎÀÚ
antirachitic factor
Ç×±¸·çº´ÀÎÀÚ(¡ì×í).
antiscorbutic factor
Ç×±«Ç÷º´ÀÎÀÚ.
antisterility factor
Ç׺ÒÀÓÀÎÀÚ(ù÷ÝÕìôì×í).
antistiffness factor
Ç×°Á÷ÀÎÀÚ(ù÷ËòÁ ì×í).
asialo von Willebrand factor
¹«Å¸¾×Æùºô·¹ºê¶õµåÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
effective dose
À¯È¿¼±·®
effective dose 50%
50% À¯È¿·®, Áß°£À¯È¿·®.
effective dose 50% =ED 50%
Áß°£À¯È¿·®, 50%À¯È¿·®.
effective dose =ED
À¯È¿·®.
effective dose equivalent
À¯È¿¼±·®´ç·®
emergency dose
ÀÀ±ÞÅõ¿©·®.
entrance dose
ÀԻ缱·®
equivalent dose
µî°¡¼±·®
equivalent uniform dose
µî°¡±ÕÁú¼±·®
erythema dose
È«¹Ý¼±·®(¡àÊåÖ)
excessive dose
°ú·®.
exit dose
´ëÃø·®(Óßö°åÖ), »çÃâ¼±·®.
exit dose
»çÃâ¼±·®, Åë°ú¼±·®
exposure dose
Á¶»ç·®.
fatal dose
Ä¡»ç·®(öÈÞÝåÖ).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½